Charles River Laboratories

Wilmington, United States Founded: 1947 • Age: 79 yrs
Provider of drug discovery and preclinical development services
Request Access

About Charles River Laboratories

Charles River Laboratories is a company based in Wilmington (United States) founded in 1947.. The company has 20,100 employees as of December 31, 2024. Charles River Laboratories has completed 29 acquisitions, including Accugenix, Agilux Laboratories and Argenta Discovery. Charles River Laboratories offers products and services including Research Models, Integrated Drug Discovery, Antibody Discovery Services, and Biologics Testing. Charles River Laboratories operates in a competitive market with competitors including Cytel, LabCorp, Precision Medicine Group, Frontage Laboratories and Precision for Medicine, among others.

  • Headquarter Wilmington, United States
  • Employees 20100 as on 31 Dec, 2024
  • Stage Public
  • Sectors
    Healthcare
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Charles River Laboratories International, Inc.
Operational Areas
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
    $4.05 B
    -1.92
    as on Dec 31, 2024
  • Net Profit
    $10.3 M
    -97.83
    as on Dec 31, 2024
  • EBITDA
    $928.62 M
    -4.78
    as on Dec 31, 2024
  • Latest Funding Round
    $1.3 M (USD), Grant

    Jun 11, 2024

  • Investors
    NIH

    & 4 more

  • Employee Count
    20100

    as on Dec 31, 2024

  • Investments & Acquisitions
    Accugenix

    & 28 more

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

IPO & Listings of Charles River Laboratories

Charles River Laboratories is a publicly listed company on the NYSE with ticker symbol CRL in USA, operating in the Commercial services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.

Exchange: NYSE · Ticker: CRL . Sector: Commercial services · USA

Products & Services of Charles River Laboratories

Charles River Laboratories offers a comprehensive portfolio of products and services, including Research Models, Integrated Drug Discovery, Antibody Discovery Services, and Biologics Testing. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Supplies animal models for basic research and testing purposes.

Accelerates discovery through comprehensive target and lead optimization services.

Offers tailored solutions for antibody therapeutic development and IND support.

Provides testing for biologics from discovery to commercialization stages.

People of Charles River Laboratories
Headcount 10000+
Employee Profiles 387
Employee Profiles
People
Marc Giulianotti Mba
Senior Business Development Executive
People
Getachew Sequar
Sr Director Business Development
People
Kerry Colligan
Senior Director, Digital And Growth Marketing
People
Jeff Simons
Director Of Digital Customer Experience

Unlock access to complete

Funding Insights of Charles River Laboratories

  • Total Funding
  • Total Rounds 10
  • Last Round Grant — $1.3M
  • First Round

    (08 Mar 2004)

  • Investors Count 5
Date Amount Transaction Name Valuation Lead Investors Investors
Jun, 2024 Amount Grant - Charles River Laboratories Valuation

investors

Jun, 2021 Amount Grant - Charles River Laboratories Valuation

investors

Oct, 2019 Amount Grant - Charles River Laboratories Valuation

investors

Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in Charles River Laboratories

Charles River Laboratories has secured backing from 5 investors, including institutional investors. Prominent investors backing the company include NIH, HHS and European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Institutional
Investor Description Founded Year Domain Location
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
Founded Year Domain Location
Drug discovery services are provided to the biopharma sector.
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by Charles River Laboratories

Charles River Laboratories has strategically engaged in corporate development activities, having acquired 29 companies. Notable acquisitions include Accugenix, Agilux Laboratories and Argenta Discovery. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Acquisitions
Company Name Description Domain Location Founded Year Amount
Detection, quality control, and veterinary services are provided worldwide.
2015
Research reagents for drug discovery and functional genomics are developed.
2012
Provider of in vitro and in vivo testing services
2011
Company Name Description Domain Location Founded Year Amount
OVO is recognized as a smart digital payment application.
2017
Bionic investment advisor platform
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014

Financial Statements - Charles River Laboratories

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Charles River Laboratories Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of Charles River Laboratories

Charles River Laboratories operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Cytel, LabCorp, Precision Medicine Group, Frontage Laboratories and Precision for Medicine, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Data analysis and statistical solutions are provided for life sciences.
domain founded_year HQ Location
Provider of laboratory tests for physicians
domain founded_year HQ Location
Provider of clinical research, development, and commercialization services for life sciences
domain founded_year HQ Location
Early drug development services are provided for pharma firms.
domain founded_year HQ Location
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Charles River Laboratories

Frequently Asked Questions about Charles River Laboratories

When was Charles River Laboratories founded?

Charles River Laboratories was founded in 1947 and raised its 1st funding round 57 years after it was founded.

Where is Charles River Laboratories located?

Charles River Laboratories is headquartered in Wilmington, United States. It is registered at Wilmington, Delaware, United States.

How many employees does Charles River Laboratories have?

As of Dec 31, 2024, the latest employee count at Charles River Laboratories is 20,100.

What is the annual revenue of Charles River Laboratories?

Annual revenue of Charles River Laboratories is $4.05B as on Dec 31, 2024.

What does Charles River Laboratories do?

Charles River Labs offers drug discovery and preclinical development services to pharma and biotech companies. Their services span the entire drug discovery pathway namely target discovery and validation, hit finding, medicinal chemistry, in vivo and in-vitro pharmacology, biomarker development, and IND-enabling studies for both small molecules and biologics. They cater to therapeutic areas such as Oncology, CNSpain, Inflammation, Immunology, Cardiovascular, Metabolic, Respiratory, Rare and neglected diseases, and others. In 2020, the company recorded annual revenues of 2.9 B and a net profit of 364.3 M.

Who are the top competitors of Charles River Laboratories?

Charles River Laboratories's top competitors include LabCorp, Cytel and Precision Medicine Group.

What products or services does Charles River Laboratories offer?

Charles River Laboratories offers Research Models, Integrated Drug Discovery, Antibody Discovery Services, and Biologics Testing.

Is Charles River Laboratories publicly traded?

Yes, Charles River Laboratories is publicly traded on NYSE under the ticker symbol CRL.

How many acquisitions has Charles River Laboratories made?

Charles River Laboratories has made 29 acquisitions, including Accugenix, Agilux Laboratories, and Argenta Discovery.

Who are Charles River Laboratories's investors?

Charles River Laboratories has 5 investors. Key investors include NIH, HHS, European Union, Foundation for Chemistry Research & Initiatives, and OSTI.GOV.

What is Charles River Laboratories's ticker symbol?

The ticker symbol of Charles River Laboratories is CRL on NYSE.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available